Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The short- and long-term outcomes of intraoperative extension of the distal bile duct margin following a positive frozen section in patients with perihilar cholangiocarcinoma remain poorly characterized. METHODS: Between 1 January 2003 and 1 January 2023, consecutive patients at seven high-volume European hepatopancreatobiliary centres undergoing major hepatectomy for perihilar cholangiocarcinoma with frozen-section analysis of the distal bile duct and subsequent intraoperative management were included retrospectively. The primary endpoint was achievement of an overall R0 resection following distal bile duct re-resection or additional pancreatoduodenectomy after identification of a positive distal bile duct frozen section. Secondary endpoints included overall survival, disease-free survival, and major postoperative complications (Clavien-Dindo grade ≥ IIIa). Outcomes were reported as adjusted hazard ratios. RESULTS: Of 785 patients undergoing major hepatectomy for perihilar cholangiocarcinoma, 594 underwent distal bile duct frozen-section analysis. A total of 66 (11.1%) intraoperative frozen sections were positive for invasive carcinoma, with an additional 7 (1.2%) false-negative findings. Distal bile duct re-resection was performed in 49 patients (74%), and 11 (16%) underwent additional pancreatoduodenectomy. Among these, 46 patients (69%) achieved distal bile duct margin clearance, with 30 (45%) ultimately attaining overall R0 resection. Overall survival was similar for patients who achieved overall R0 status via distal bile duct re-resection or pancreatoduodenectomy and those with overall R0 margins after primary negative distal bile duct frozen section (adjusted hazard ratio 0.84, 95% confidence interval 0.49 to 1.44; P = 0.536). Conversely, overall R1 resection was associated with significantly worse overall survival (adjusted hazard ratio 1.82, 1.43 to 2.33; P < 0.001). Complications graded ≥ IIIa and 90-day mortality did not differ significantly between groups undergoing distal bile duct re-resection, pancreatoduodenectomy or no intervention (P = 0.126 and P = 0.121, respectively). CONCLUSION: In selected patients, re-resection or additional pancreatoduodenectomy after positive distal bile duct frozen-section analysis is associated with long-term survival without significantly increasing major morbidity or mortality.
Source: BJS Open
Institutions: Karolinska University Hospital, Copenhagen University Hospital, Rigshospitalet, Karolinska Institutet, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, IRCCS Ospedale San Raffaele, University of Verona, Erasmus MC, Oslo University Hospital, University of Oslo, University of Copenhagen
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,881
OpenAlex ID: W7140073478
